Biologically T-ALL is hallmarked by genomic/genetic lesions impacting on a number of targetable pathways, comprising Notch, JAK/STAT, PI3K/Akt/mTOR, and MAPK signaling pathway [3, 4]. The gene discussed is SOAT1; the disease is acute lymphoblastic leukemia.